Clinical Trial Update: A Safety and Dose-Finding Study of SYNT001 in Subjects With Pemphigus (Vulgaris or Foliaceus) [Phase 1, Phase 2]

View source ↗

Summary

A safety and dose-finding study of SYNT001 in pemphigus (vulgaris or foliaceus) was conducted in Phase 1/2 and subsequently terminated; results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pemphigus
• Pemphigus Foliaceus
• Pemphigus Vulgaris

Drugs mentioned

• SYNT001 (SYNT001)

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Pemphigus, Pemphigus Vulgaris | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2020-02-05